A Qualitative Study on CSII in Children and Adolescents Having Type 1 Diabetes
NCT ID: NCT03066284
Last Updated: 2017-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2016-03-14
2019-03-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To explore the experiences of adolescents and their parents and parents ofi children with type 1 diabetes in Kuwait about the use of Insulin Pump Therapy (IPT) in the context of their quality of life.
2. To gain in-depth understanding of the perceptions of adolescents and their parents and parents of children with type 1 diabetes in Kuwait with T1DM about IPT and its use for diabetes management.
Design A qualitative case study methodology will be adopted using semi-structured interviews for data gathering. Interviews will be conducted with a purposive sample including adolescents and their parents and parents of children with type 1 diabetes in Kuwait with T1D, who are on CSII therapy at least 12 months, along with their parents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adolescents between the age of 11 and 18 or children between 2 and 10 years old
* Kuwaiti or expats
* Duration of CSII (Insulin Pump Therapy) at least 12 months.
* Prior to starting Insulin Pump Therapy must have been on MDI for a minimum of 12 months
* Attend the Insulin Pump clinic at DDI
Exclusion Criteria
* Presence of a learning disability
* Diagnosis of any diabetes complication before starting the CSII therapy
* Diagnosis of psychological problem
4 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dasman Diabetes Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
nehad Taha
Senior Diabetes Educator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nehad A. Taha, MSc.
Role: PRINCIPAL_INVESTIGATOR
Dasman Diabetes Institute
Naglaa I. Mesbah, MSc.
Role: PRINCIPAL_INVESTIGATOR
Dasman Diabetes Institute
Zahra N. Rahme, MSc.
Role: PRINCIPAL_INVESTIGATOR
Dasman Diabetes Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dasman Diabetes Institute
Sharq, Kuwait City, Kuwait
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nehad A. Taha, MSc.
Role: primary
Zahraa N. Rahme, MSc.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RA 2016-006
Identifier Type: -
Identifier Source: org_study_id